Osteonecrosis Due to Drugs, Jaw

2

Review clinical trials related to Osteonecrosis Due to Drugs, Jaw. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Human Amniotic Membrane (hAM) for Stage II Maxillomandibular Osteonecrosis Management

This study aims to demonstrate, during the first standard surgical management of patients with stage II MRONJ, the effect of the implantation of a cryopreserved hAM on the maxillomandibular bone, on the healing of the oral mucosa.

Participants needed: 66
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Centre Hospitalier Universitaire de BesanconUpdated: Sep 19, 2024Locations: 5
Eligibility criteria

Men and women over the age of 18 [+21]

During surgery: Discovery of an interrupting MRONJ with damage to the basilar ed... [+4]

Status: Recruiting

Medication Related Osteonecrosis of the Jaws (MRONJ) in a Cohort of Patients Treated by Antiresorptive Drugs

The objective of this prospective observational study is to investigate the incidence of Medication Related Osteonecrosis of the Jaws (MRONJ) in patients receiving antiresorptive drugs for oncohematologic reasons during a 5-year follow-up. Secondary objectives are to compare the different antiresorptive drugs in relation to the incidence of MRONJ and to identify any systemic as well as local risk factors.

Participants needed: 126
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Catholic University of the Sacred HeartUpdated: Jun 20, 2024Locations: 1
Eligibility criteria

Patients with specific prescription to initiate therapy with antiresorptive drug...

Previous Head and Neck Radiotherapy